Latest News of CBRGW
SPAC Chain Bridge I to Take Phytanix Bio Public
By MarketWatch |
3 months ago
Chain Bridge I, a blank-check company, is set to acquire Phytanix Bio, a company focusing on cannabinoid medicines. Founded by ex-GW Pharmaceuticals members, the deal values Phytanix Bio at $58 millio...